Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 4
1974 2
1975 1
1976 3
1977 2
1978 6
1979 13
1980 6
1981 1
1982 3
1983 13
1984 4
1985 12
1986 39
1987 9
1988 14
1989 16
1990 14
1991 26
1992 14
1993 29
1994 17
1995 14
1996 41
1997 15
1998 29
1999 28
2000 27
2001 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
Pathogenesis of thrombosis.
Prentice CR. Prentice CR. Haemostasis. 1990;20 Suppl 1:50-9. doi: 10.1159/000216161. Haemostasis. 1990. PMID: 2083873 Review.
The pathogenesis of thrombosis involves consideration of two processes: atherosclerosis and thrombosis. ...In veins the atherosclerotic process does not occur, and thrombosis is precipitated by immobility often associated with accidental or surgical trauma. . …
The pathogenesis of thrombosis involves consideration of two processes: atherosclerosis and thrombosis. ...In veins the athero …
Heparin-induced thrombocytopenia.
Kelton JG. Kelton JG. Haemostasis. 1986;16(2):173-86. doi: 10.1159/000215288. Haemostasis. 1986. PMID: 3519379 Review.
Finally, a small subset of patients with heparin-induced thrombocytopenia develop the disastrous complication of heparin-induced thrombocytopenia plus arterial thrombosis. Some of these patients die. In this review, we will summarize some of the issues concerning heparin-i …
Finally, a small subset of patients with heparin-induced thrombocytopenia develop the disastrous complication of heparin-induced thrombocyto …
Cancer and thrombosis.
Donati MB. Donati MB. Haemostasis. 1994 Mar-Apr;24(2):128-31. doi: 10.1159/000217092. Haemostasis. 1994. PMID: 7959360 Review.
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. ...Recently, emphasis has been given to the potential risk of cancer therapy (both surgery and chemotherapy) in enhancing the risk for thromboembolic diseas …
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. ...Recently, emp …
Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient.
Ray JG, Burows RF, Ginsberg JS, Burrows EA. Ray JG, et al. Haemostasis. 2000 May-Jun;30(3):103-17. doi: 10.1159/000022532. Haemostasis. 2000. PMID: 11014960 Review.
The likely cause of death among patients with paroxysmal nocturnal hemoglobinuria was described in nine studies: 22.2% of fatalities were due to venous thrombosis (95% CI 11.8-38.0), more commonly in western countries (event rate 37.2%, 95% CI 21.6-56.0). ...CONCLUSION: In …
The likely cause of death among patients with paroxysmal nocturnal hemoglobinuria was described in nine studies: 22.2% of fatalities were du …
Venous thrombosis: prevalence and interaction of risk factors.
Rosendaal FR. Rosendaal FR. Haemostasis. 1999 Dec;29 Suppl S1:1-9. doi: 10.1159/000054106. Haemostasis. 1999. PMID: 10629398 Review.
The key to understanding why certain individuals develop deep vein thrombosis at varying times, despite similar risk factors being present, is the realization of the importance of gene-gene and gene-environment interactions between risk factors. The discovery of factor V L …
The key to understanding why certain individuals develop deep vein thrombosis at varying times, despite similar risk factors being pr …
Neutrophils and deep venous thrombosis.
Stewart GJ. Stewart GJ. Haemostasis. 1993 Mar;23 Suppl 1:127-40. doi: 10.1159/000216922. Haemostasis. 1993. PMID: 8495864 Review.
A case can be made for the participation of polymorphonuclears (PMN) in the initiation and propagation of venous thrombosis. In animal models leukocytes adhered to areas of veins that serve as sites for initiation of thrombi in patients. ...Lidocaine and one of its derivat …
A case can be made for the participation of polymorphonuclears (PMN) in the initiation and propagation of venous thrombosis. In anima …
Antiphospholipid-thrombosis syndromes.
Bick RL, Arun B, Frenkel EP. Bick RL, et al. Haemostasis. 1999;29(2-3):100-10. doi: 10.1159/000022492. Haemostasis. 1999. PMID: 10629391 Review.
Antiphospholipid antibodies are strongly associated with thrombosis and appear to be the most common of the acquired blood protein defects causing thrombosis. Based upon our experience, approximately 25% of patients with unexplained venous thrombosis, approxi …
Antiphospholipid antibodies are strongly associated with thrombosis and appear to be the most common of the acquired blood protein de …
Past, present and future of hirudin.
Markwardt F. Markwardt F. Haemostasis. 1991;21 Suppl 1:11-26. doi: 10.1159/000216258. Haemostasis. 1991. PMID: 1894186 Review.
The efficacy of hirudin in preventing venous and arterial thrombosis and disseminated intravascular coagulation was demonstrated in various animal models. ...
The efficacy of hirudin in preventing venous and arterial thrombosis and disseminated intravascular coagulation was demonstrated in v …
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
Hirsh J. Hirsh J. Haemostasis. 1996 Oct;26 Suppl 4:189-98. doi: 10.1159/000217298. Haemostasis. 1996. PMID: 8979124 Review.

LMWH has been compared with unfractionated heparin in the treatment of venous thrombosis. The results of a pooled analysis studies of hospitalized patients showed a significant reduction of thrombus size, p < 0.001 and in the incidence of recurrent venous thromboembolis

…
LMWH has been compared with unfractionated heparin in the treatment of venous thrombosis. The results of a pooled analysis studies of …
413 results